Fully Funded PhD Opportunities in Advanced Gene and Cell Therapy – MSCA COFUND RAREFIND
Pubblicato il 27-10-2026 - Fondazione Telethon ETS in Italia
pOrganisation/Company Fondazione Telethon ETS Research Field Biological sciences Chemistry Medical sciences Pharmacological sciences Other Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 31 Dec 2026 - 23:59 (Europe/Rome) Country Italy Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Nov 2027 Is the job funded through the EU Research Framework Programme? Horizon Europe – COFUND Marie Curie Grant Agreement Number Is the Job related to staff position within a Research Infrastructure? No /p pThe fully funded positions focus on experimental research in bgene editing /b and bgene therapy /b, addressing btherapeutic applications for inherited retinal diseases, enzymatic deficiency disorders, lysosomal storage disorders, and cancer. /b Fellows will also engage with cutting-edge approaches, including bgenome and epigenome editing, miRNA-based therapeutics, vector engineering, and immuno-oncology. /b Trainees will agevolazioni from a highly collaborative environment and state-of-the-art facilities across the Fondazione Telethon institutes. /p ul liHold a bMaster’s degree (or equivalent) /bin life sciences, medicine, pharmacy, chemistry, or related disciplines. /li liNot already hold (or have defended) ba doctoral degree. /b /li liComply with the bMSCA mobility rule /b: applicants must not have lived or carried out their main activities (work, studies) in Italy for more than b12 months in the 36 months /bimmediately before the call deadline. /li liDemonstrate bstrong proficiency in English /b, both spoken and written. /li /ul pLanguages ENGLISH Level Excellent /p h3Additional Information /h3 ul libEmployment salary: /bThe gross annual base salary amounts to €32,840,
plus any applicable family allowances, in accordance with the rules of the MSCA programme. The amount indicated is gross and is subject to the tax and social security deductions provided for under Italian law. /li /ul pTax relief and incentives under Article 44 of Decree Law No. 78/2010 ("Return of Researchers" scheme): Candidates who meet the eligibility requirements may benefit from a reduction of up to 90% of taxable income, resulting in significantly lower tax deductions and a substantial increase in net salary. /p ul libLeave social security: /bPaid sick leave, maternity/paternity/parental leave, and comprehensive social coverage. /li libFacilities services: /bAccess to state-of-the-art labs at TIGEM and SR-TIGET, strong admin and PMT support, EURAXESS migration/relocation assistance (visas, permits), induction materials (e.g., Welcome Kit), and on-site childcare options. /li libTraining career development (credit-bearing): /bStructured curriculum (ECTS), summer school, conference on research integrity, workshop on translation/regulation, weekly seminars and data clubs, plus Career Development Plan and mentoring. /li libIntersectoral international exposure: /bPlanned secondments between TIGEM and SR-TIGET across basic, translational, and clinical environments; interactions with connected biotech companies. /li /ul h3Work Location(s) /h3 pNumber of offers available 5 Company/Institute TIGEM - Telethon Institute of Genetics and Medicine Country Italy City Pozzuoli (Na) Postal Code 80078 Street Via Campi Flegrei, 34 Geofield /p pNumber of offers available 5 Company/Institute SR-Tiget - San Raffaele Telethon Institute for Gene Therapy Country Italy City Milano Postal Code 20132 Street Via Olgettina, 60 Geofield /p #J-18808-Ljbffr